Secondary Mutations Correct Fitness Defects in Toxoplasma gondii With Dinitroaniline Resistance Mutations

被引:26
|
作者
Ma, Christopher [1 ]
Tran, Johnson [1 ]
Li, Catherine [1 ]
Ganesan, Lakshmi [1 ]
Wood, David [1 ]
Morrissette, Naomi [1 ]
机构
[1] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
基金
美国国家卫生研究院;
关键词
D O I
10.1534/genetics.108.092494
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Dinitroanilines (oryzalin, trifluralin, ethafluralin) disrupt microtubules in protozoa but not in vertebrate cells, causing selective death of intracellular Toxoplasma gondii parasites without affecting host cells. Parasites containing alpha 1-tubulin point mutations are dinitroaniline resistant but show increased rates of aberrant. replication relative to wild-type parasites. T. gondii parasites bearing the F52Y mutation were previously demonstrated to spontaneously acquire two intragenic mutations that decrease both resistance levels and replication defects. Parasites bearing the G142S mutation are largely dependent on oryzalin for viable growth in culture. We isolated 46 T. gondii lines that have suppressed microtubule defects associated with the G142S or the F52Y mutations by acquirring secondary mutations. These compensatory mutations were alpha 1-tubulin pseudorevertants or extragenic Suppressors (the majority alter the beta 1-tubulin gene). Many secondary mutations were located in tubulin domains that suggest that they function by destabilizing microtubules. Most strikingly, we identified seven novel mutations that localize to an eight-amino-acid insert that stabilizes the alpha 1-tubulin M loop, including one (P364R) that acts as a compensatory mutation in both F52Y and G142S lines. These lines have reduced dinitroaniline resistance but most perform better than parental lines in competition assays, indicating that there is a trade-off between resistance and replication fitness.
引用
收藏
页码:845 / 856
页数:12
相关论文
共 50 条
  • [1] In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase
    Reynolds, MG
    Oh, J
    Roos, DS
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (04) : 1271 - 1277
  • [2] The fitness costs of antibiotic resistance mutations
    Melnyk, Anita H.
    Wong, Alex
    Kassen, Rees
    [J]. EVOLUTIONARY APPLICATIONS, 2015, 8 (03): : 273 - 283
  • [3] Characterization of cytochrome b from Toxoplasma gondii and Qo domain mutations as a mechanism of atovaquone-resistance
    McFadden, DC
    Tomavo, S
    Berry, EA
    Boothroyd, JC
    [J]. MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 2000, 108 (01) : 1 - 12
  • [4] Mutations in a-tubulin confer dinitroaniline resistance at a cost to microtubule function
    Ma, Christopher
    Li, Catherine
    Ganesan, Lakshmi
    Oak, Jean
    Tsai, Susan
    Sept, David
    Morrissette, Naomi S.
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (12) : 4711 - 4720
  • [5] Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii
    Farrell, Andrew
    Coleman, Bradley I.
    Benenati, Brian
    Brown, Kevin M.
    Blader, Ira J.
    Marth, Gabor T.
    Gubbels, Marc-Jan
    [J]. BMC GENOMICS, 2014, 15
  • [6] Novel α-Tubulin Mutations Conferring Resistance to Dinitroaniline Herbicides in Lolium rigidum
    Chu, Zhizhan
    Chen, Jinyi
    Nyporko, Alex
    Han, Heping
    Yu, Qin
    Powles, Stephen
    [J]. FRONTIERS IN PLANT SCIENCE, 2018, 9
  • [7] Whole genome profiling of spontaneous and chemically induced mutations in Toxoplasma gondii
    Andrew Farrell
    Bradley I Coleman
    Brian Benenati
    Kevin M Brown
    Ira J Blader
    Gabor T Marth
    Marc-Jan Gubbels
    [J]. BMC Genomics, 15
  • [8] Identification of mutations in TgMAPK1 of Toxoplasma gondii conferring resistance to 1NM-PP1
    Sugi, Tatsuki
    Kobayashi, Kyousuke
    Takemae, Hitoshi
    Gong, Haiyan
    Ishiwa, Akiko
    Murakoshi, Fumi
    Recuenco, Frances C.
    Iwanaga, Tatsuya
    Horimoto, Taisuke
    Akashi, Hiroomi
    Kato, Kentaro
    [J]. INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2013, 3 : 93 - 101
  • [9] Impact of Fluoroquinolone Resistance Mutations on Gonococcal Fitness and In Vivo Selection for Compensatory Mutations
    Kunz, Anjali N.
    Begum, Afrin A.
    Wu, Hong
    D'Ambrozio, Jonathan A.
    Robinson, James M.
    Shafer, William M.
    Bash, Margaret C.
    Jerse, Ann E.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (12): : 1821 - 1829
  • [10] Fitness cost of drug resistance mutations is relative and is modulated by other resistance mutations:: implications for persistance of transmitted resistance
    Cong, M
    Bennett, DE
    Heneine, W
    García-Lerma, JG
    [J]. ANTIVIRAL THERAPY, 2005, 10 : S169 - S169